THE EFFECT OF MELATONIN, METFORMIN AND URSODEOXYCHOLIC ACID ON NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, DOUBLE-BLINDED CONTROLLED TRIAL | ||||
Bulletin of Pharmaceutical Sciences Assiut University | ||||
Volume 46, Issue 1, June 2023, Page 347-360 PDF (939.83 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/bfsa.2023.301123 | ||||
View on SCiNiTO | ||||
Authors | ||||
Kourosh Mojtahedi ; Farahnaz Joukar ; Seyyed Hossein Seyyed Nezhad Fahim; Sara Yeganeh ; Mehrnaz Asgharnezhad; Afshin Shafaghi; Saba Fakhrieh Asl; Fariborz Mansour-Ghanaei | ||||
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran | ||||
Abstract | ||||
Objective: This study was to investigate and compare the effect of melatonin, metformin, and ursodeoxycholic acid (UDCA) on non-alcoholic fatty liver disease(NAFLD). Methods: In this randomized double-blinded clinical trial, 120 patients with NAFLD who had been referred to Gastrointestinal and Liver Diseases Research Center, Rasht, Iran, between September 2015 and January 2016. Patients were randomly assigned to 4 groups. Each group received melatonin, metformin, UDCA, or placebo in addition to a weight loss diet for 3 months. Results: A significant reduction was observed in levels of steatosis, alanine aminotransferase, alkaline phosphatase, body weight, BMI, waist circumstance and triacylglycerol among participants in groups with metformin or melatonin administration. In addition a significant decrease in fasting plasma glucose, and total cholesterol concentration was detected following metformin and UDCA administration, respectively. Conclusions: The present study suggests that the addition of metformin or melatonin to a low-caloric diet may be effective in the treatment of patients with NAFLD. | ||||
Keywords | ||||
Melatonin; Metformin; Ursodeoxycholic acid; Non-alcoholic fatty liver disease | ||||
Statistics Article View: 212 PDF Download: 215 |
||||